NCT07058025: Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants
- State
- Not started
- Phase
- Phase 2
- People
- 168 planned
- Started
- 1 Oct 2025
- Primary completion
- 30 Sep 2028
- Arms
- Intervention group will receive multiple IV doses of UC-MSCs
- Results
- None posted
- 10 Jul 2025: Trial registered